Q1 Earnings Forecast for ZimVie Issued By B. Riley

ZimVie Inc. (NASDAQ:ZIMV) – Stock analysts at B. Riley issued their Q1 2025 earnings per share (EPS) estimates for shares of ZimVie in a report released on Wednesday, April 9th. B. Riley analyst A. Schock expects that the company will post earnings per share of ($0.01) for the quarter. B. Riley currently has a “Strong-Buy” rating on the stock. The consensus estimate for ZimVie’s current full-year earnings is $0.60 per share. B. Riley also issued estimates for ZimVie’s Q2 2025 earnings at ($0.02) EPS, Q3 2025 earnings at ($0.08) EPS, Q4 2025 earnings at $0.01 EPS, FY2025 earnings at ($0.10) EPS, Q1 2026 earnings at $0.02 EPS, Q2 2026 earnings at $0.07 EPS, Q3 2026 earnings at $0.01 EPS, Q4 2026 earnings at $0.12 EPS and FY2026 earnings at $0.22 EPS.

ZimVie (NASDAQ:ZIMV) last released its earnings results on Wednesday, February 26th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.02. The firm had revenue of $111.52 million for the quarter, compared to the consensus estimate of $113.67 million. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%.

Separately, Needham & Company LLC reissued a “hold” rating on shares of ZimVie in a report on Wednesday, April 9th.

ZimVie Trading Down 1.5 %

ZimVie stock opened at $9.30 on Monday. ZimVie has a 12 month low of $8.56 and a 12 month high of $22.40. The company has a current ratio of 1.94, a quick ratio of 1.38 and a debt-to-equity ratio of 0.57. The stock’s 50 day simple moving average is $11.79 and its two-hundred day simple moving average is $13.41. The firm has a market cap of $258.98 million, a PE ratio of -0.71 and a beta of 2.14.

Hedge Funds Weigh In On ZimVie

Several institutional investors and hedge funds have recently bought and sold shares of the company. Wealth Enhancement Advisory Services LLC grew its holdings in shares of ZimVie by 5.8% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 15,127 shares of the company’s stock worth $211,000 after purchasing an additional 836 shares during the period. Bank of New York Mellon Corp increased its holdings in ZimVie by 0.9% during the 4th quarter. Bank of New York Mellon Corp now owns 100,638 shares of the company’s stock worth $1,404,000 after purchasing an additional 943 shares during the period. Rhumbline Advisers lifted its stake in ZimVie by 3.0% in the fourth quarter. Rhumbline Advisers now owns 45,214 shares of the company’s stock worth $631,000 after acquiring an additional 1,303 shares during the last quarter. SG Americas Securities LLC increased its holdings in ZimVie by 15.7% in the fourth quarter. SG Americas Securities LLC now owns 11,110 shares of the company’s stock valued at $155,000 after buying an additional 1,508 shares during the last quarter. Finally, Principal Financial Group Inc. lifted its stake in ZimVie by 9.8% during the fourth quarter. Principal Financial Group Inc. now owns 19,054 shares of the company’s stock worth $266,000 after purchasing an additional 1,702 shares during the last quarter. 95.63% of the stock is currently owned by institutional investors and hedge funds.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.